Neuromuscular HOMEepAGE
neuromuscular.wustl.edu
/
A–Z

Guillain-Barré-like syndrome with serum IgM binding to GalNAc-GD1a ganglioside

Immune/Antibody
W
View full entry on WUSTL Neuromuscular
antibody/gbs.htm#Guillain-Barré-like syndrome with serum IgM binding to GalNA

Overview

From WUSTL Neuromuscular

Epidemiology Japanese patients Younger onset: Mean 3rd decade ? Female > Male Clinical Prodrome GI: Campylobacter jejuni (75%) Respiratory: Cytomegalovirus Weakness: Mild; Proximal + Distal Sensory: Paresthesias ± Loss (75%); More common with CMV prodrome Cranial nerves: Facial weakness (27% to 80%); More common with CMV prodrome Recovery: Good at 1 month; Better than with IgG or no antibodies Electrodiagnostic Demyelination in many (38% to 64%) Axonal loss uncommon Serum antibody IgM vs GalNAc-GD1a ganglioside Cross reactive with GM2 ganglioside: 100% with CMV prodrome; 50% with GI prodrome P

Related Conditions

Shared genes
"Classic" Guillain-Barré Syndrome
H131GD1A
Acute Immune Polyneuropathies
GD1APATHOLOGY
Acute Motor (Axonal) Neuropathy (AMAN)
IIGQ1BGM1
ACUTE NEUROPATHIES
GD1A
Antibodies vs Glycolipids & Glycoproteins
GM1MAGGQ1B
C. Anti-GM1 Antibodies
GM1IGMGM1LMN
Chronic Immune Demyelinating Neuropathies: Variants
GD1AMOTORGM1
Classification of Acute Immune Neuropathies
GD1A

External Resources

WUSTL Neuromuscular
Washington University Disease Center
PubMed
Biomedical Literature
GeneReviews
NCBI Expert-Authored Reviews
Orphanet
Portal for Rare Diseases
NORD
National Organization for Rare Disorders

Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.